Home » News » CROs/Service Providers » H. D. Smith acquisition Triplefin

H. D. Smith acquisition Triplefin

Monday, September 30, 2013

H. D. Smith, a pharmaceutical wholesaler and services provider based in Springfield, Ill., has acquired Triplefin, a reimbursement, patient assistance and pharmaceutical brand-support services company headquartered in Cincinnati, Ohio. H. D. Smith secured majority representation on Triplefin’s board of directors in January and majority stock ownership interest in May. H.D. Smith has now acquired the remaining 49% of Triplefin shares, giving the company full ownership.

Triplefin will operate as a wholly owned subsidiary of H. D. Smith within the H. D. Smith specialty solutions operating unit. Financial terms were not disclosed.

The combined organization will continue to provide support services to traditional brand and specialty product manufacturers and pharmacy partners, including critical distribution and fulfillment functions, patient assistance and reimbursement programs, third-party logistics, pharmaceutical marketing and product education.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!